Vascular and metabolic effects of treatment of combined hyperlipidemia: Focus on statins and fibrates

This publication has 109 references indexed in Scilit:

• Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions
  Published by Elsevier ,2005
• Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-α Activators
  Hypertension, 2005
• Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats
  Biochemical and Biophysical Research Communications, 2005
• The benefit of fibrates in the treatment of ‘bad HDL-C responders to statins’
  International Journal of Cardiology, 2005
• Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region
  Circulation, 2004
• Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR
  Biochemical and Biophysical Research Communications, 2003
• PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation
  Hypertension, 2002
• Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPARα/RXRα and Decrease the Transactivation of NFκB
  Biochemical and Biophysical Research Communications, 2002
• Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers
  The Journal of Clinical Pharmacology, 2000
• Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease
  Coronary Artery Disease, 1996